INDICATIONS

UrgoTul Absorb is indicated for:

• All exuding acute wounds (2nd degree burns, skin abrasions, traumatic wounds, post-operative wounds) and chronic wounds (leg ulcers, pressure ulcers and diabetic foot ulcers)
• The local treatment of fungating wounds in combination with a specific treatment

Due to the non-adhesive nature of the dressing, UrgoTul Absorb is recommended in the treatment of wounds in which the surround skin is weakened.

CONTRAINDICATIONS

• Known sensitivity to the dressing

PRECAUTIONS

• The soft-adherent TLC layer of UrgoTul Absorb can adhere to latex surgical gloves. It is recommended to avoid contact with the soft-adherent TLC layer.
• If clinical signs of local infection are noted, treatment can be changed to an antibacterial dressing dependent on clinical judgement.
• UrgoTul Absorb must not be used in a hyperbaric chamber.
• Single use sterile individual packaging: re-using a single use dressing may lead to risks of infection.
• Check that the sterile protector is intact before use. Do not use if package is damaged.
• Do not re-sterilize the dressing.

PRODUCT OPTIONS

Supplied in boxes of individually packed sterile dressings.

CLINICAL EVIDENCE

1. Bernard FX, et al. Stimulation of the proliferation of human dermal fibroblasts in vitro by a lipidocolloid dressing. J Wound Care. 2005;14(5):215-221